Mark J Alles Turning Point Therapeutics, Inc. (TPTX) insider trading activity

TPTX Quotes by TradingView

Mark J Alles is Director of Turning Point Therapeutics, Inc.. Currently has a direct ownership of 0 shares of TPTX, which is worth approximately $0. The most recent transaction as insider was on Aug 17, 2022, when has been sold 2,000 shares (Common Stock) at a price of $76.0 per share, resulting in proceeds of $152,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Mark J Alles Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 17 2022
SELL
Sale (or disposition) back to the issuer
$152,000 $76.0 p/Share
2,000 Reduced 100.0%
0 Common Stock
Jun 21 2021
BUY
Open market or private purchase
$162,680 $81.34 p/Share
2,000 Added 50.0%
2,000 Common Stock

Also insider at

SYRS
Syros Pharmaceuticals, Inc. Healthcare
Director
BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
Director
MJA

Mark J Alles

Director
San Diego, CA

Track Institutional and Insider Activities on TPTX

Follow Turning Point Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPTX shares.

Notify only if

Insider Trading

Get notified when an Turning Point Therapeutics, Inc. insider buys or sells TPTX shares.

Notify only if

News

Receive news related to Turning Point Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TPTX